What investment strategy does TechLife Capital focus on?

TechLife Capital focuses on Growth strategies in the private equity space.

How many portfolio companies does TechLife Capital have?

TechLife Capital has 14 active portfolio companies and 2 completed exits and 2 funds tracked on GP Intel.

Where is TechLife Capital headquartered?

TechLife Capital is headquartered in Paris, France.

What is TechLife Capital's assets under management?

TechLife Capital manages approximately €150M in assets under management.

When was TechLife Capital founded?

TechLife Capital was founded in 2018.

What sectors does TechLife Capital invest in?

TechLife Capital invests across Healthcare, Software, Business Services.

What are TechLife Capital's recent exits?

Recent realized exits by TechLife Capital include: Atempo (2025) to HorizonH and NewFund; Maxxing (2025) to Optimix Solutions.

Home/GPs/TechLife Capital

DetailCard

TechLife Capital

Paris, France·Founded 2018·

Growth Equity

·techlifecapital.com

Paris-based growth equity firm founded in 2018, focused on mid-market healthcare and technology scale-ups through TechLife Capital I (2018, EUR 100M flagship) and TechLife Capital II (2024). AMF-registered and TIBI-labelled for innovation financing, with 3 partners and 10 operating partners split between healthcare and technology. First exits in 2025: Atempo, sold to the HorizonH consortium in May, and Maxxing, merged with Optimix Solutions in July at an IRR above 50 percent.

AUM

€150M

Funds

vintages 2018–2024

Portfolio

Exits

TechLife Capital is a Paris growth equity firm with €150M AUM, 14 active companies and 2 exits.

SectorsHealthcare Software Business Services

Key takeaways

·Top sector focus: TMT (38% of portfolio).
·Fund cadence: ~6Y between vintages · last raise 2024.

Sector breakdown

16 companies

TMT

6 · 38%

HealthTech

2 · 13%

Biotech

2 · 13%

Software

2 · 13%

MedTech

1 · 6%

SaaS

1 · 6%

Pharma

1 · 6%

Healthcare

1 · 6%

Key facts

HQParis, France

Founded2018

Websitetechlifecapital.com

Recent exits

TechLife Capital sold Atempo to HorizonH and NewFund in 2025 after 7 years.

TechLife Capital sold Maxxing to Optimix Solutions in 2025 after 5 years.

Coverage notes

2 funds tracked, 16 portfolio companies (14 active · 2 realized). Verified weekly from public filings and deal announcements.

Funds & portfolio

Every fund TechLife Capital has raised, with its portfolio companies. Hand-checked from public filings.

2 funds

Fund

Strategy

Vintage

Size

Assets

Exits

TechLife Capital II

Growth2024€50M7 assets

Growth

2024 · 2yr

€50M

–

Unrealized

7 held

Company	Entry
Ad Scientiam HealthTech · France	2025
Créative TMT · France	2025
Evolutis MedTech · France	2023
Flash Therapeutics Biotech · France	2021
MyData Trust TMT · France	2021
Quinten Health HealthTech · France	2022
Studia Software · France	2026

TechLife Capital I

Growth2018€100M7 assets2 exits

Growth

2018 · 8yr

€100M

Unrealized

7 held

Company	Entry
ADS TMT · France	2019
CNSI TMT · France	2020
MDT TMT · France	2020
MITEM Pharma Pharma · France	2020
RNAlead Biotech · France	2021
Venn TMT · France	2020
XPath Healthcare · France	2021

Realized

2 exits

Company	Entry	Exit	Type	Buyer	MOIC
Atempo Software · France	2018	2025	Trade Sale	HorizonH and NewFund	–
Maxxing SaaS · France	2020	2025	Trade Sale	Optimix Solutions	–

About TechLife Capital

TechLife Capital is a Paris-based growth equity private equity firm with €150 million of assets under management, founded in 2018 and focused on Healthcare and Technology mid-market scale-ups. The firm deploys across TechLife Capital I (vintage 2018, €100M flagship) and TechLife Capital II (vintage 2024, €50M proxy), with AMF registration and Tibi label alignment supporting institutional French limited partner relationships.

Investment thesis

TechLife Capital targets European Healthcare and Technology mid-market scale-ups, deploying growth equity capital with equity tickets typically ranging from €5 million to €20 million per transaction. Sector focus spans HealthTech, MedTech, enterprise software and selective B2B technology verticals, with the dual healthcare-technology mandate enabling cross-vertical insights into digital health and HealthTech innovation themes.

Recent activity

Recent realised exits include Atempo (TMT, 2025) and Maxxing (TMT, 2025), reflecting active distribution across the technology portfolio. The platform tracks 2 funds, 11 active portfolio companies and 2 realised exits across the multi-vintage healthcare and technology growth equity programme.

Frequently asked questions

What investment strategy does TechLife Capital focus on?: TechLife Capital focuses on Growth strategies in the private equity space.
How many portfolio companies does TechLife Capital have?: TechLife Capital has 14 active portfolio companies and 2 completed exits and 2 funds tracked on GP Intel.
Where is TechLife Capital headquartered?: TechLife Capital is headquartered in Paris, France.
What is TechLife Capital's assets under management?: TechLife Capital manages approximately €150M in assets under management.
When was TechLife Capital founded?: TechLife Capital was founded in 2018.
What sectors does TechLife Capital invest in?: TechLife Capital invests across Healthcare, Software, Business Services.
What are TechLife Capital's recent exits?: Recent realized exits by TechLife Capital include: Atempo (2025) to HorizonH and NewFund; Maxxing (2025) to Optimix Solutions.